PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) was the target of a large decline in short interest in June. As of June 15th, there was short interest totaling 45,319 shares, a decline of 55.2% from the May 31st total of 101,221 shares. Based on an average daily trading volume, of 82 shares, the days-to-cover ratio is presently 552.7 days.
PureTech Health Stock Performance
Shares of PTCHF opened at $1.70 on Monday. PureTech Health has a twelve month low of $1.55 and a twelve month high of $1.92. The business’s 50-day moving average price is $1.75 and its 200-day moving average price is $1.70.
About PureTech Health
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Recommended Stories
- Five stocks we like better than PureTech Health
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
